A new quantitative relation between internal and external steady-state concentrations in active transport

Zusammenfassung Im aktiven Transport der Aminosäureanalogen (-Aminoisobuttersäure und Cyclopentan-1-aminocarbonsäure) in Gehirnschnitten folgt das Verhältnis im stationären Zustand zwischen der intrazellulären Konzentration und der Lösungskonzentration derFreundlich Adsorptionisotherme,C _i =AC ₀ ⁿ . Dieses Verhältnis stimmt mit dem Modell einer aktiven Pumpe, die der Michaelis-Menten Kinetik folgt und mit einer passiven Ausdiffusion ausgeglichen ist, nicht überein. Es wird vermutet, dass eine Kontrolle des aktiven Transports durch intra- und extrazelluläre Konzentrationen reguliert wird.     

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

Linkage disequilibrium (LD) mapping provides a powerful method for fine-structure localization of rare disease genes, but has not yet been widely applied to common disease. We sought to design a systematic approach for LD mapping and apply it to the localization of a gene (IBD5) conferring susceptibility to Crohn disease. The key issues are: (i) to detect a significant LD signal (ii) to rigorously bound the critical region and (iii) to identify the causal genetic variant within this region. We previously mapped the IBD5 locus to a large region spanning 18 cM of chromosome 5q31 (P<10(-4)). Using dense genetic maps of microsatellite markers and single-nucleotide polymorphisms (SNPs) across the entire region, we found strong evidence of LD. We bound the region to a common haplotype spanning 250 kb that shows strong association with the disease (P< 2 x 10(-7)) and contains the cytokine gene cluster. This finding provides overwhelming evidence that a specific common haplotype of the cytokine region in 5q31 confers susceptibility to Crohn disease. However, genetic evidence alone is not sufficient to identify the causal mutation within this region, as strong LD across the region results in multiple SNPs having equivalent genetic evidence-each consistent with the expected properties of the IBD5 locus. These results have important implications for Crohn disease in particular and LD mapping in general.     

A cycloisomerization reaction of Di-(p-halogenophenyl)-trifluoromethyl-carbinols

Résumé Une solution de di-(p-chlorophényl)-trifluorométhyl-carbinol dans l'acide sulfurique concentré, diluée à l'eau ou au méthanol, donne naissance à du chloro-3-hydroxy-(ou méthoxy-)-6-trifluorométhyl-9 fluorène. Le composé méthoxylé, après l'alcoolyse alcaline du groupement-CF₃, a été dégradé au fluorénone correspondant, dont la synthèse a été realisée indépendamment.     

Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells

Receptors for the Fc portion of immunoglobulins or for the third component of complement (C3) are present on a variety of circulating and fixed tissue cells including granulocytes, monocytes, lymphocytes and glomerular epithelial cells. Cells which lack Fc receptors may express them after infection by herpes simplex virus (HSV)-1, HSV-2, cytomegalovirus or varicella zoster virus. We recently reported that infection by HSV-1 induces both Fc and C3 receptors on human endothelial cells. Glycoprotein E of HSV-1 has been shown to function as an Fc receptor. We now demonstrate that glycoprotein C (gC) of HSV-1 functions as a C3b receptor. This receptor appears following HSV-1, but not HSV-2, infection. Detection of the C3b receptor is blocked by monoclonal antibodies to glycoprotein C (gC) of HSV-1, but not by monoclonal antibodies to other HSV-1 glycoproteins. In addition, the MP mutant of HSV-1, which lacks gC, fails to express a C3b receptor. These results assign a new function of gC of HSV-1 and demonstrate potentially important differences between HSV-1 and HSV-2 glycoproteins.     

Evidence for an activating effect of tabernathine on rat brain catechlomine synthesis and elimination

Summary Tabernanthine increased the synthesis and elimination of catecholamines (CA) in the striatum and the rest of the brain, but not in the hypothalamus. These data provide evidence that tabernanthine may activate CA turnover of some brain structures by acting at 2 steps of the metabolic pathway. The results are discussed in relation to a central stimulating action and a hypoxia antagonistic effect of this drug.Acknowledgments. Tabernanthine was generously provided by the Institut de Chimie des Substances Naturelles of the C.N.R.S., Gifsur-Yvette, by B. Poiteau, Dat-Xuong, H. P. Husson, Mme Ch. Kan-Fan and P. Potier.     

Demonstration of a soluble factor capable of inhibiting allogenic lymphocyte proliferation in man]

During the secondary mixed lymphocyte reaction (MLR), i.e. after the double in vitro allogenic sensitization between responding and stimulating cells bearing at least one HLA-DR incompatibility, suppressor cells are developed [1]. They are able to inhibit a primary MLR provided that the stimulating cells possess the same DR incompatibility as the immunizing cells. We report here that this inhibition is due to the production by these cells of a soluble suppressor factor which acts on responding cells provided that they share at least one gene product of the HLA-D region with the cells producing the factor. This a feedback process of auto-inhibition occurring after hyperimmunization. The action of this suppressor factor seems to be genetically restricted to an as yet unknown locus in linkage disequilibrium with HLA-DR.